Demographics (2)
- AGE_DX_MO - Age in months at the time of diagnosis (phv00427169.v1.p1)
- SEX - Self-reported sex (phv00427168.v1.p1)
Race and Ethnicity (2)
- ETHNICITY - Self-reported ethnicity (phv00427171.v1.p1)
- RACE - Self-reported race (phv00427170.v1.p1)
Other (28)
- ANALYTE_TYPE - Analyte type (phv00409170.v1.p1)
- COHORT - Source of tissue or DNA (phv00427176.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00409166.v1.p1)
- EF_TIME_DAYS - Number of days from diagnosis to event or last follow up (phv00427177.v1.p1)
- EVENT - Did the subject have tumor relapse or progression (phv00427175.v1.p1)
- FILE1 - File 1 (phv00427184.v1.p1)
- FILE2 - File 2 (phv00427185.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00409172.v1.p1)
- HISTOLOGY - Shimada histologic classification of tumor (phv00427172.v1.p1)
- IS_TUMOR - Tumor status (phv00409171.v1.p1)
- MYCN - MYCN amplification status of tumor (phv00427173.v1.p1)
- OS_TIME_DAYS - Number of days from diagnosis to death or last follow up (phv00427178.v1.p1)
- PAIRED - Are sequencing data paired (phv00427183.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00409173.v1.p1)
- RISK - Assigned risk group (phv00427167.v1.p1)
- SAMPLE_ID - Sample ID (phv00409169.v1.p1)
- SAMPLE_ID - Sample ID (phv00409168.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00409175.v1.p1)
- SUBJECT_ID - Subject ID (phv00427165.v1.p1)
- SUBJECT_ID - Subject ID (phv00409165.v1.p1)
- SUBJECT_ID - Subject ID (phv00409167.v1.p1)
- TIMEPOINT - Treatment status at time of sample collection (phv00427182.v1.p1)
- TUMOR_COHORT - Tumor stage of sample (phv00409174.v1.p1)
- TUMOR_HISTOLOGY - Shimada histologic classification of tumor (phv00427180.v1.p1)
- TUMOR_MYCN - MYCN amplification status of tumor (phv00427181.v1.p1)
- TUMOR_RISK - Assigned risk group (phv00427179.v1.p1)
- VITAL - Is the subject alive (phv00427174.v1.p1)
- YEAR_DX - Year of diagnosis (phv00427166.v1.p1)